Clinical Trials Logo

Filter by:
NCT ID: NCT04540497 Active, not recruiting - Clinical trials for IgG4 Related Disease

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

Start date: October 26, 2020
Phase: Phase 3
Study type: Interventional

This study aims to evaluate the efficacy and safety of inebilizumab for the prevention of flare of Immunoglobulin G4-related disease (IgG4-RD).

NCT ID: NCT04540302 Active, not recruiting - Venous Occlusion Clinical Trials

The Merit WRAPSODY AV Access Efficacy Study (WAVE)

WAVE
Start date: March 9, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlusion within the dialysis access outflow circuit

NCT ID: NCT04540276 Active, not recruiting - Clinical trials for Myocardial Infarction

Intraoperative Hyperoxia and MINS

Start date: February 4, 2018
Phase:
Study type: Observational

Oxygen therapy is administered to all patients during general anesthesia to maintain tissue oxygenation and prevent hypoxia and ischemia. However, liberal use of oxygen may lead to hyperoxia and some studies suggest that supranormal levels of arterial oxygen saturation may lead to complications. In this post hoc substudy of the VISION cohort, we plan to assess the association between perioperative inspired oxygen fraction (FiO2) and myocardial injury after non-cardiac surgery (MINS).

NCT ID: NCT04540003 Completed - Clinical trials for Educational Achievement

School Based Health Care: A Model for Improving Educational Achievement for Children in Inner City Schools

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

Developmental problems have tremendous impact on children, affecting academic achievement and mental health later in life.The process of receiving a developmental assessment is long and arduous, and may require multiple physician visits taking over one year. Although a relatively new concept in Canada, School-Based Health Centres (SBHCs) have been successfully implemented in over 1900 schools in the United States.The first SBHC in Ontario, and Canada as a whole, was established through the Model Schools Pediatric Health Initiative (MSPHI) and is dedicated to reducing health inequities for inner city children by reducing barriers and providing accessible clinical care. To provide more conclusive evidence on the relative benefits of SBHCs as compared to traditional health care access, this study will use a prospective cohort quasi-experimental study design to compare differences in educational achievement for developmental assessments in the SBHC model relative to standard care. As per standard of care, students having difficulty in school are identified by the Toronto District School Board (TDSB) internal research staff and are presented to the monthly School Support team (SST) meetings. Historically physicians do not attend SST meetings, however, as a part of the SBHC program, pediatricians will participate in monthly SST meetings. Schools assigned to the intervention group will have SBHC physicians attend SST meetings, while schools assigned to the control group will not. The overall objective of this study is to examine educational achievement, as defined by standardized test scores and report cards in students who use an inner city SBHCs for developmental concerns relative to those who do not. We hypothesize students attending schools in which SST meetings have a pediatrician present, that are referred to a SBHC, will score higher and show a greater increase in standardized test scores and report cards (from baseline to follow-up) than students attending schools in which SST meetings do not have a pediatrician present and access services through traditional means in the community (standard of care).The secondary objectives are: a) to examine socio-demographic data for these students and its relationship to educational achievement and b) to determine wait times to developmental assessment for students in the intervention group who attend the SBHCs using retrospective chart review.

NCT ID: NCT04539860 Recruiting - Blood Pressure Clinical Trials

Comparison of Blood Pressure Measurements Between Transdermal Optical Imaging and Standard of Care

Start date: August 25, 2020
Phase:
Study type: Observational

Participants (patients and volunteers) will be recruited to have their blood pressure measured by standard blood pressure assessment methods while having their face video recorded. The data collected will help improve the blood pressure measurement accuracy of Transdermal Optical Imaging, which relies on machine learning to extract physiological information from videos recorded.

NCT ID: NCT04539665 Recruiting - Crohn Disease Clinical Trials

Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.

Start date: September 27, 2019
Phase: N/A
Study type: Interventional

The study is looking at the role of the mesentery in disease recurrence for ileocolic Crohn's disease. It is a prospective study that has been designed to perform extended mesenteric excision on patients undergoing their first ileocolic resection for Crohn's disease. Endoscopic recurrence will be monitored with the hypothesis that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection.

NCT ID: NCT04539509 Withdrawn - Clinical trials for Mild Traumatic Brain Injury

Post-Concussion Aerobic Exercise

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This study is looking at the specific role of an exercise prescription on recovery from concussion symptoms in the general population.

NCT ID: NCT04539405 Completed - Clinical trials for Laparoscopic General, Gynecological and Urologic Surgeries

Evaluation of the Sevoflurane Consumption During General Anesthesia When Using the MemsorbTM Membrane

MEMSEV
Start date: May 4, 2021
Phase:
Study type: Observational [Patient Registry]

The study aims at determining whether replacing the classical chemical absorber Dräegersorb 800+ on Dräeger Perseus A500 machines (Dräeger, Lübeck, Germany) by the new membrane technology-based product (Memsorbâ„¢, DMF Medical Inc., Halifax, NS, Canada) with the help of high-quality monitoring (BIS and NOL) and high-end ventilators (Dräeger Perseus A500 machines; Dräeger, Lübeck, Germany) that allow minimal fresh gas flow, will significantly decrease the use of sevoflurane and its related atmospheric pollution.

NCT ID: NCT04539223 Recruiting - Clinical trials for Carotid Artery Stenosis

A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy

SLICE-CEA
Start date: August 28, 2020
Phase: Phase 4
Study type: Interventional

This is a multicenter, randomized, open label study with blinded outcome assessment to evaluate the impact of additional/intensive LDL-cholesterol reduction with evolocumab on carotid artery atherosclerotic plaques in higher risk subjects with severe asymptomatic but vulnerable plaques.

NCT ID: NCT04539041 Active, not recruiting - Clinical trials for Progressive Supranuclear Palsy (PSP)

Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy

Start date: February 16, 2021
Phase: Phase 1
Study type: Interventional

This is a phase 1, multi-center, double-blind, placebo-controlled, multiple dose escalation study with NIO752 in progressive supranuclear palsy (PSP) participants.